VESALIUS BIOCAPITAL PARTNERS
Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception. With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financing rounds. Their companies are based in Europe allowing easy interaction with management. They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
VESALIUS BIOCAPITAL PARTNERS
Social Links:
Industry:
Financial Services Venture Capital
Founded:
2007-01-01
Status:
Active
Contact:
+352 26 84 56 82
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Wordpress Plugins Nginx Euro
Similar Organizations
CDH Investments
CDH Investments is an international alternative asset fund manager with more than $2.0 billion of committed capital under management.
Felix Capital
Felix Capital is a venture fund that focuses on digital commerce, digital media, and information technology companies.
Section 32
Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-10 | Scenic Biotech | Vesalius Biocapital Partners investment in Series A - Scenic Biotech | 28 M EUR |
| 2022-02-16 | Memo Therapeutics | Vesalius Biocapital Partners investment in Series B - Memo Therapeutics | 23 M CHF |
| 2021-10-12 | Rejuvenate Biomed | Vesalius Biocapital Partners investment in Series B - Rejuvenate Biomed | 15.7 M EUR |
| 2021-09-16 | Caresyntax | Vesalius Biocapital Partners investment in Series C - Caresyntax | 130 M USD |
| 2021-07-29 | Topas Therapeutics | Vesalius Biocapital Partners investment in Series B - Topas Therapeutics | 18 M EUR |
| 2021-03-02 | Rejuvenate Biomed | Vesalius Biocapital Partners investment in Series A - Rejuvenate Biomed | 3.2 M EUR |
| 2021-01-29 | Sword Health | Vesalius Biocapital Partners investment in Series B - Sword Health | 25 M USD |
| 2020-11-19 | Catalym | Vesalius Biocapital Partners investment in Series B - Catalym | 50 M EUR |
| 2020-10-19 | Topas Therapeutics | Vesalius Biocapital Partners investment in Series B - Topas Therapeutics | 22 M EUR |
| 2020-02-27 | Sword Health | Vesalius Biocapital Partners investment in Series A - Sword Health | 9 M USD |